Joint Shantou International Eye Center (JSIEC) of Shantou University & the Chinese University of Hong Kong, Shantou, China.
Retina. 2022 Sep 1;42(9):1702-1708. doi: 10.1097/IAE.0000000000003527.
Retinal detachment is a severe complication of acute retinal necrosis, threatening vision. The published articles on the effectiveness of laser in preventing retinal detachment in acute retinal necrosis are controversial. Therefore, we aim to evaluate whether prophylactic laser is effective for retinal detachment after acute retinal necrosis.
PubMed, Embase, and Cochrane databases were searched, and the retrieved records were screened. Each included study has well-defined laser-treated group and control group without laser treatment or with enough data for manual grouping. The quality of the included studies was assessed using ROBINS-I ("Risk Of Bias In Nonrandomized Studies-of Interventions"). Meta-analysis was conducted to calculate the pooled odds ratios and their 95% confidence interval. Sensitivity analysis was used to test the solidarity, and subgroup analysis was performed to determine the source of heterogeneity.
Fourteen studies with a total of 532 eyes were eventually included. The quality of the included studies was moderate. The combined results showed that the pooled odds ratio was 0.61 (95% confidence interval [0.41∼0.90], P < 0.05, I 2 = 27%). Sensitivity analysis showed that the odds ratios were similar when excluding any study. Subgroup analysis showed moderate heterogeneity among three subgroups (I 2 = 48.0%, P = 0.15 for heterogeneity), and the odds ratio in antiviral therapy and steroid combined with prophylactic laser was 0.43 (95% confidence interval [0.25∼0.74], P < 0.05, I 2 = 0%).
In patients with acute retinal necrosis, laser photocoagulation is an effective treatment to prevent retinal detachment, especially in the subgroup combined with antiviral therapy and steroid.
视网膜脱离是急性坏死性视网膜病变的严重并发症,威胁视力。关于激光预防急性坏死性视网膜病变后视网膜脱离的有效性的已发表文章存在争议。因此,我们旨在评估预防性激光治疗对急性坏死性视网膜病变后视网膜脱离是否有效。
检索 PubMed、Embase 和 Cochrane 数据库,并筛选检索到的记录。每个纳入的研究都有明确界定的激光治疗组和对照组,没有激光治疗或有足够数据进行手动分组。使用 ROBINS-I(“干预措施非随机研究的偏倚风险”)评估纳入研究的质量。进行荟萃分析以计算合并的优势比及其 95%置信区间。进行敏感性分析以测试团结性,并进行亚组分析以确定异质性的来源。
最终纳入了 14 项研究,共 532 只眼。纳入研究的质量为中等。合并结果显示,合并优势比为 0.61(95%置信区间 [0.41∼0.90],P < 0.05,I 2 = 27%)。敏感性分析显示,排除任何一项研究后,优势比相似。亚组分析显示,在抗病毒治疗和类固醇联合预防性激光治疗的三个亚组中存在中度异质性(I 2 = 48.0%,P = 0.15 用于异质性),抗病毒治疗和类固醇联合预防性激光治疗的优势比为 0.43(95%置信区间 [0.25∼0.74],P < 0.05,I 2 = 0%)。
在急性坏死性视网膜病变患者中,激光光凝是预防视网膜脱离的有效治疗方法,尤其是在联合抗病毒治疗和类固醇的亚组中。